JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayer, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayer, S. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 204-212, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


THE PHYSIOLOGICAL DISPOSITION OF H3-DICHLOROISOPROTERENOL

Steven E. Mayer 1

1 Department of Pharmacology, Division of Basic Health Sciences, Emory University, Atlanta, Georgia

The fate of dichloroisoproterenol (DCI), labelled with H3 on the beta position, has been investigated in dogs and mice using intravenous doses of 7 to 10 mg/kg. In the dog, DCI rapidly disappeared from plasma (half-life of 1.4 minutes), but this phase was followed by two others with progressively slower rates of disappearance. The rapid initial disappearance of the drug from plasma was associated with extensive localization in most tissues, especially the lung. High concentrations of DCI were also found in various parts of the dog brain, which is in contrast to what has been reported for the catecholamines. Furthermore, tissue localization was associated with a long duration of action, which again distinguishes this blocking drug from the action of the catecholamines. Rapid metabolism of DCI was demonstrated by the finding that less than half of the radioactivity found in plasma 20 minutes after administration was due to the drug. The metabolites were present in large amounts in urine, but not in tissues, and were identified as 3,4-dichloromandelic acid and the glucosiduronate and probably sulfate conjugates of DCI.

The mouse, in contrast to the dog, was shown to metabolize DCI by removing H3 from the beta position of the molecule. Evidence was the loss of radioactivity from the whole mouse and the large fraction of H3 which was found in the water of the animals.

Submitted on July 20, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.